LMO2

Information LMO2

Description

LMO2 encodes a cysteine-rich, two LIM-domain protein that is required for yolk sac erythropoiesis. The LMO2 protein has a central and crucial role in hematopoietic development and is highly conserved. The LMO2 transcription start site is located approximately 25 kb downstream from the 11p13 T-cell translocation cluster (11p13 ttc), where a number T-cell acute lymphoblastic leukemia-specific translocations occur. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Nov 2008]

Full Name

LIM domain only 2

Source NCBI

ReMap Statistics

Datasets
5
Biotypes
3
Peaks
159,046
Non-redundant peaks
121,499

TF Classification

Super Class
Unknown
Class
Unknown
Familly
Unknown
Sub Familly
Unknown

Source TFClass

External IDs

JASPAR
Ensembl
ENSG00000135363
UniProt
P25791
Genevisible
P25791
RefSeq
NM_001142315
Aliases
LMO-2; RBTN2; RBTNL1; RHOM2; TTG2
All peaks LMO2
Download BED file
Non redundant peaks LMO2
Download BED file
SEQUENCES LMO2
Download FASTA file
DOWNLOAD All ReMap
Got to catalogue

Datasets Table for LMO2

Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks
LMO2 CCRF-CEM GEO Homo sapiens GSE33850 64,084
LMO2 Kasumi-1 GEO Homo sapiens GSE43834 6,524
LMO2 Kasumi-1 SICTR GEO Homo sapiens GSE60130 33,021
LMO2 Kasumi-1 SIRUNX1ETO GEO Homo sapiens GSE60130 23,373
LMO2 TSU-1621MT GEO Homo sapiens GSE60477 32,044
Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.